# | Title | Journal | Year | Citations |
---|
1 | Diabetes is a risk factor for the progression and prognosis of COVID‐19 | Diabetes/Metabolism Research and Reviews | 2020 | 1,106 |
2 | Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes | Diabetes/Metabolism Research and Reviews | 1999 | 1,065 |
3 | Quality of life and diabetes | Diabetes/Metabolism Research and Reviews | 1999 | 862 |
4 | Phlorizin: a review | Diabetes/Metabolism Research and Reviews | 2005 | 772 |
5 | The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO-MCBN, the American Diabetes Association and the German Diabetes Society | Diabetes/Metabolism Research and Reviews | 2001 | 765 |
6 | Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management | Diabetes/Metabolism Research and Reviews | 2011 | 675 |
7 | Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update) | Diabetes/Metabolism Research and Reviews | 2020 | 442 |
8 | Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update) | Diabetes/Metabolism Research and Reviews | 2020 | 418 |
9 | IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes | Diabetes/Metabolism Research and Reviews | 2016 | 417 |
10 | Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy | Diabetes/Metabolism Research and Reviews | 2012 | 412 |
11 | Common infections in diabetes: pathogenesis, management and relationship to glycaemic control | Diabetes/Metabolism Research and Reviews | 2007 | 411 |
12 | Standards of medical care for type 2 diabetes in China 2019 | Diabetes/Metabolism Research and Reviews | 2019 | 404 |
13 | Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies | Diabetes/Metabolism Research and Reviews | 2004 | 383 |
14 | Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases | Diabetes/Metabolism Research and Reviews | 2006 | 373 |
15 | International consensus and practical guidelines on the management and the prevention of the diabetic foot | Diabetes/Metabolism Research and Reviews | 2000 | 360 |
16 | Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity | Diabetes/Metabolism Research and Reviews | 2011 | 359 |
17 | Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 (Covid‐19) | Diabetes/Metabolism Research and Reviews | 2021 | 352 |
18 | Practical guidelines on the management and prevention of the diabetic foot 2011 | Diabetes/Metabolism Research and Reviews | 2012 | 349 |
19 | Glucose-stimulated signaling pathways in biphasic insulin secretion | Diabetes/Metabolism Research and Reviews | 2002 | 337 |
20 | Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection | Diabetes/Metabolism Research and Reviews | 2004 | 316 |
21 | Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management | Diabetes/Metabolism Research and Reviews | 2011 | 315 |
22 | The mode of action of thiazolidinediones | Diabetes/Metabolism Research and Reviews | 2002 | 314 |
23 | What is the most effective way to reduce incidence of amputation in the diabetic foot? | Diabetes/Metabolism Research and Reviews | 2000 | 313 |
24 | Diabetes risk score: towards earlier detection of Type 2 diabetes in general practice | Diabetes/Metabolism Research and Reviews | 2000 | 308 |
25 | Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease | Diabetes/Metabolism Research and Reviews | 2006 | 302 |
26 | Intermediate metabolism in normal pregnancy and in gestational diabetes | Diabetes/Metabolism Research and Reviews | 2003 | 285 |
27 | Practical guidelines on the management and prevention of the diabetic foot | Diabetes/Metabolism Research and Reviews | 2008 | 285 |
28 | Vascular disease and diabetes: is hypoglycaemia an aggravating factor? | Diabetes/Metabolism Research and Reviews | 2008 | 283 |
29 | Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta‐analysis and systemic review | Diabetes/Metabolism Research and Reviews | 2011 | 276 |
30 | Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update) | Diabetes/Metabolism Research and Reviews | 2020 | 276 |
31 | Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction | Diabetes/Metabolism Research and Reviews | 2006 | 270 |
32 | The AGE-receptor in the pathogenesis of diabetic complications | Diabetes/Metabolism Research and Reviews | 2001 | 268 |
33 | Patient perceptions of diabetes and diabetes therapy: assessing quality of life | Diabetes/Metabolism Research and Reviews | 2002 | 266 |
34 | The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence‐based global consensus | Diabetes/Metabolism Research and Reviews | 2016 | 262 |
35 | Circulating levels of free insulin-like growth factors in obese subjects: the impact of Type 2 diabetes | Diabetes/Metabolism Research and Reviews | 1999 | 260 |
36 | Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment | Diabetes/Metabolism Research and Reviews | 2008 | 254 |
37 | Sensors for glucose monitoring: technical and clinical aspects | Diabetes/Metabolism Research and Reviews | 2001 | 253 |
38 | Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives | Diabetes/Metabolism Research and Reviews | 2003 | 253 |
39 | Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance | Diabetes/Metabolism Research and Reviews | 2004 | 251 |
40 | Glucagon-like peptide 1(GLP-1) in biology and pathology | Diabetes/Metabolism Research and Reviews | 2005 | 250 |
41 | Insulin resistance in type 2 diabetes: role of fatty acids | Diabetes/Metabolism Research and Reviews | 2002 | 247 |
42 | Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta‐analysis | Diabetes/Metabolism Research and Reviews | 2012 | 244 |
43 | Prevention of foot ulcers in the at‐risk patient with diabetes: a systematic review | Diabetes/Metabolism Research and Reviews | 2016 | 244 |
44 | Engineering and characterization of the long‐acting glucagon‐like peptide‐1 analogue LY2189265, an Fc fusion protein | Diabetes/Metabolism Research and Reviews | 2010 | 242 |
45 | The role of taurine in diabetes and the development of diabetic complications | Diabetes/Metabolism Research and Reviews | 2001 | 238 |
46 | Standards of care for type 2 diabetes in China | Diabetes/Metabolism Research and Reviews | 2016 | 236 |
47 | Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c) | Diabetes/Metabolism Research and Reviews | 2012 | 234 |
48 | A report from the international consensus on diagnosing and treating the infected diabetic foot | Diabetes/Metabolism Research and Reviews | 2004 | 233 |
49 | Diabetic neuropathy and oxidative stress | Diabetes/Metabolism Research and Reviews | 2006 | 232 |
50 | Prevention and management of foot problems in diabetes: a Summary Guidance for Daily Practice 2015, based on the IWGDF Guidance Documents | Diabetes/Metabolism Research and Reviews | 2016 | 232 |